FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2524637936> ?p ?o ?g. }

• W2524637936 endingPage "2195" @default.
• W2524637936 startingPage "2184" @default.
• W2524637936 abstract "BACKGROUND: Metformin use has been associated with a reduced risk of developing cancer and an improvement in overall cancer survival rates in meta-analyses, but, to date, evidence to support the use of metformin as an adjuvant therapy in individual cancer types has not been presented. PATIENTS AND METHODS: We systematically searched research databases, conference abstracts and trial registries for any studies reporting cancer outcomes for individual tumour types in metformin users compared with non-users, and extracted data on patients with early-stage cancer. Studies were assessed for design and quality, and a meta-analysis was conducted to quantify the adjuvant effect of metformin on recurrence-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS), to inform future trial design. RESULTS: Of 7670 articles screened, 27 eligible studies were identified comprising 24 178 participants, all enrolled in observational studies. In those with early-stage colorectal cancer, metformin use was associated with a significant benefit in all outcomes [RFS hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.47-0.85; OS HR 0.69, CI 0.58-0.83; CSS HR 0.58, CI 0.39-0.86]. For men with early-stage prostate cancer, metformin was associated with significant, or borderline significant, benefits in all outcomes (RFS HR 0.83, CI 0.69-1.00; OS HR 0.82, CI 0.73-0.93; CSS HR 0.58, CI 0.37-0.93); however, there was significant heterogeneity between studies. The data suggest that prostate cancer patients treated with radical radiotherapy may benefit more from metformin (RFS HR 0.45, CI 0.29-0.70). In breast and urothelial cancer, no significant benefits were identified. Sufficient data were not available to conduct analyses on the impact of metformin dose and duration. CONCLUSIONS: Our findings suggest that metformin could be a useful adjuvant agent, with the greatest benefits seen in colorectal and prostate cancer, particularly in those receiving radical radiotherapy, and randomised, controlled trials which investigate dose and duration, alongside efficacy, are advocated." @default.
• W2524637936 created "2016-10-07" @default.
• W2524637936 creator A5000991231 @default.
• W2524637936 creator A5011703751 @default.
• W2524637936 creator A5036820514 @default.
• W2524637936 creator A5045701481 @default.
• W2524637936 date "2016-12-01" @default.
• W2524637936 modified "2023-10-15" @default.
• W2524637936 title "Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis" @default.
• W2524637936 cites W1585462082 @default.
• W2524637936 cites W1896360033 @default.
• W2524637936 cites W1935841376 @default.
• W2524637936 cites W1964760331 @default.
• W2524637936 cites W1965830162 @default.
• W2524637936 cites W1969273270 @default.
• W2524637936 cites W1973668609 @default.
• W2524637936 cites W1976655891 @default.
• W2524637936 cites W1987698903 @default.
• W2524637936 cites W1988778035 @default.
• W2524637936 cites W1992786512 @default.
• W2524637936 cites W1996713943 @default.
• W2524637936 cites W2000066094 @default.
• W2524637936 cites W2000396770 @default.
• W2524637936 cites W2010942419 @default.
• W2524637936 cites W2013047715 @default.
• W2524637936 cites W2025874220 @default.
• W2524637936 cites W2033381611 @default.
• W2524637936 cites W2033556635 @default.
• W2524637936 cites W2035632263 @default.
• W2524637936 cites W2040608814 @default.
• W2524637936 cites W2042008937 @default.
• W2524637936 cites W2042243090 @default.
• W2524637936 cites W2044428844 @default.
• W2524637936 cites W2048994966 @default.
• W2524637936 cites W2055249407 @default.
• W2524637936 cites W2057218469 @default.
• W2524637936 cites W2059116757 @default.
• W2524637936 cites W2062018857 @default.
• W2524637936 cites W2063130014 @default.
• W2524637936 cites W2064656431 @default.
• W2524637936 cites W2068407327 @default.
• W2524637936 cites W2069605185 @default.
• W2524637936 cites W2074889838 @default.
• W2524637936 cites W2075642745 @default.
• W2524637936 cites W2076643714 @default.
• W2524637936 cites W2078767636 @default.
• W2524637936 cites W2082400559 @default.
• W2524637936 cites W2087358018 @default.
• W2524637936 cites W2088095316 @default.
• W2524637936 cites W2093294518 @default.
• W2524637936 cites W2094501815 @default.
• W2524637936 cites W2095695954 @default.
• W2524637936 cites W2098725808 @default.
• W2524637936 cites W2102937816 @default.
• W2524637936 cites W2103299694 @default.
• W2524637936 cites W2107102367 @default.
• W2524637936 cites W2107328434 @default.
• W2524637936 cites W2118038328 @default.
• W2524637936 cites W2119184048 @default.
• W2524637936 cites W2121225884 @default.
• W2524637936 cites W2132657939 @default.
• W2524637936 cites W2135902771 @default.
• W2524637936 cites W2138691465 @default.
• W2524637936 cites W2140164776 @default.
• W2524637936 cites W2143104968 @default.
• W2524637936 cites W2145857851 @default.
• W2524637936 cites W2146318891 @default.
• W2524637936 cites W2146511561 @default.
• W2524637936 cites W2148710188 @default.
• W2524637936 cites W2149179641 @default.
• W2524637936 cites W2153716722 @default.
• W2524637936 cites W2157304020 @default.
• W2524637936 cites W2158731007 @default.
• W2524637936 cites W2162362429 @default.
• W2524637936 cites W2163702740 @default.
• W2524637936 cites W2166393423 @default.
• W2524637936 cites W2167436791 @default.
• W2524637936 cites W2288971050 @default.
• W2524637936 doi "https://doi.org/10.1093/annonc/mdw410" @default.
• W2524637936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5178140" @default.
• W2524637936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27681864" @default.
• W2524637936 hasPublicationYear "2016" @default.
• W2524637936 type Work @default.
• W2524637936 sameAs 2524637936 @default.
• W2524637936 citedByCount "307" @default.
• W2524637936 countsByYear W25246379362016 @default.
• W2524637936 countsByYear W25246379362017 @default.
• W2524637936 countsByYear W25246379362018 @default.
• W2524637936 countsByYear W25246379362019 @default.
• W2524637936 countsByYear W25246379362020 @default.
• W2524637936 countsByYear W25246379362021 @default.
• W2524637936 countsByYear W25246379362022 @default.
• W2524637936 countsByYear W25246379362023 @default.
• W2524637936 crossrefType "journal-article" @default.
• W2524637936 hasAuthorship W2524637936A5000991231 @default.
• W2524637936 hasAuthorship W2524637936A5011703751 @default.
• W2524637936 hasAuthorship W2524637936A5036820514 @default.
• W2524637936 hasAuthorship W2524637936A5045701481 @default.

• next